The Effect of Vibration Therapy on the Bone Density of the Tiba in Patients With Spinal Cord Injury
NCT ID: NCT00624988
Last Updated: 2008-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
10 participants
INTERVENTIONAL
2008-07-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vibration Therapy
Treatment will consist of 10 sessions of 60 seconds each with one minute intervals in between at 50 Hz frequency three times per week for three months.
Vibration Therapy
Treatment will consist of 10 sessions of 60 seconds each with one minute intervals in between at 50 Hz frequency three times per week for three months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vibration Therapy
Treatment will consist of 10 sessions of 60 seconds each with one minute intervals in between at 50 Hz frequency three times per week for three months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A spinal cord injury patient with injury above T12
* Injury below T4 to avoid respiratory complication.
* An ASIA classification of A or B
Exclusion Criteria
* Exercise where electrical therapy is used while the trial is being conducted
* A bone density measure 3 times below normal mineralization levels as measured on the first bone density scan prior to entry in to the study
* Surgical implants below the level of T12
* Local infection, acute inflammation, injury, tumors or other malignancy, recent wounds, diabetes
* Any unstable joints of the lower extremity, recent hip and knee joints or fitted hip or knee pins, bolts and/or plates
* Acute thrombosis
* Severe migraine, epilepsy
* Serious cardiovascular disease, wearing a pacemaker
* Any Spinal manipulation within one year of the study
* Any implanted device or prosthesis or intrauterine IUD type of device pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Logan College of Chiropractic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Logan University, College of Chiropractic
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David V Lenihan, DC, PhD
Role: PRINCIPAL_INVESTIGATOR
Logan College of Chiropractic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Logan College of Chiropractic
Chesterfield, Missouri, United States
Logan College of Chiropractic
Chesterfield, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Dennis Enix, DC, MBA
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD0723070100
Identifier Type: -
Identifier Source: org_study_id